Impact of Anti-CD20 Antibodies on the Incidence of Secondary Cancers in Patients Treated for Chronic Lymphocytic Leukemia

被引：0
|
作者：
Guidez, Stephanie [1 ]
Demarquette, Helene [1 ]
Nudel, Morgane [1 ]
Le Grand, Charline [2 ]
Boyle, Eileen [1 ]
Herbaux, Charles [1 ]
Facon, Thierry [1 ]
Cazin, Bruno [1 ]
Morschhauser, Franck [1 ]
机构：
[1] CHRU Lille, Hop Claude Huriez, Malad Sang, F-59037 Lille, France
[2] CHRU Lille, Hop Claude Huriez, F-59037 Lille, France
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Orphan-drug status granted to new anti-CD20 monoclonal antibody for chronic lymphocytic leukemia
    不详
    FUTURE ONCOLOGY, 2010, 6 (01) : 10 - 10
  • [42] Is there a role for anti-CD20 antibodies in CLL?
    Shah, Harsh R.
    Stephens, Deborah M.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 68 - 75
  • [43] Clinical applications of anti-CD20 antibodies
    Gopal, AK
    Press, OW
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 134 (05): : 445 - 450
  • [44] Dancing partners at the ball: Rational selection of next generation anti-CD20 antibodies for combination therapy of chronic lymphocytic leukemia in the novel agents era
    Butler, L. A.
    Tam, C. S.
    Seymour, J. F.
    BLOOD REVIEWS, 2017, 31 (05) : 318 - 327
  • [45] Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells
    Patz, Michaela
    Isaeva, Polina
    Forcob, Nche
    Mueller, Bianka
    Frenzel, Lukas P.
    Wendtner, Clemens-Martin
    Klein, Christian
    Umana, Pablo
    Hallek, Michael
    Krause, Guenter
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (03) : 295 - 306
  • [46] Allogeneic immunity and anti-CD20 therapy: a potent combination in the treatment of a patient with Richter transformation of chronic lymphocytic leukemia
    Tam, Constantine S.
    LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 7 - 8
  • [47] Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: a phase I study in chronic lymphocytic leukemia*
    Kalaycio, Matt E.
    Negrea, O. George
    Allen, Steven L.
    Rai, Kanti R.
    Abbasi, Rashid M.
    Horne, Heather
    Wegener, William A.
    Goldenberg, David M.
    LEUKEMIA & LYMPHOMA, 2016, 57 (04) : 803 - 811
  • [48] Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia
    Adamo, Francesco Maria
    Barcelos, Estevao Carlos Silva
    De Falco, Filomena
    Dorillo, Erica
    Rompietti, Chiara
    Sorcini, Daniele
    Stella, Arianna
    Del Papa, Beatrice
    Baldoni, Stefano
    Esposito, Angela
    Geraci, Clelia
    Arcaleni, Roberta
    Pennetta, Chiara
    Ragonese, Francesco
    Moretti, Lorenzo
    Mameli, Mariagrazia
    Di Ianni, Mauro
    Rosati, Emanuela
    Fioretti, Bernard
    Sportoletti, Paolo
    CANCERS, 2023, 15 (14)
  • [49] Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series
    Susanne Rüfenacht
    Pascal Gantenbein
    Katia Boggian
    Domenica Flury
    Lukas Kern
    Günter Dollenmaier
    Philipp Kohler
    Werner C. Albrich
    Infection, 2022, 50 : 783 - 790
  • [50] Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series
    Rufenacht, Susanne
    Gantenbein, Pascal
    Boggian, Katia
    Flury, Domenica
    Kern, Lukas
    Dollenmaier, Gunter
    Kohler, Philipp
    Albrich, Werner C.
    INFECTION, 2022, 50 (03) : 783 - 790
12345